Skip to main content
. 2023 Aug 8;4(8):101143. doi: 10.1016/j.xcrm.2023.101143

Table 3.

Performance of triage for the detection of CIN3+ among 391 hrHPV+ women (validation set)

Triage algorithms Colposcopy referral rates (%) (n/N) Sensitivity (%) (n/N) 95% CI Specificity (%) (n/N) 95% CI PPV (%) (n/N) 95% CI NPV (%) (n/N) 95% CI NNC Compared with TCT(ASCUS+)
Compared with HPV16/18 or TCT(ASCUS+)
Relative Sensitivity (95%CI) Relative specificity (95%CI) Relative Sensitivity (95%CI) Relative specificity (95%CI)
TCT(ASCUS+) 74.42 (291/391) 85.44 (135/158) 78.75–90.36 33.05 (77/233) 27.12–39.54 46.39 (135/291) 40.58–52.30 77.00 (77/100) 67.31–84.58 2.16 1 1
HPV16/18 41.94 (164/391) 58.86 (93/158) 50.75–66.53 69.53 (162/233) 63.12–75.28 56.71 (93/164) 48.75–64.34 71.37 (162/227) 64.94–77.06 1.76 0.69 (0.59–0.80) 2.10 (1.71–2.59)
ZNF671m 51.15 (200/391) 78.48 (124/158) 71.10–84.45 67.38 (157/233) 60.90–73.28 62.00 (124/200) 54.85–68.68 82.20 (157/191) 75.87–87.20 1.61 0.92 (0.84–1.00) 2.04 (1.68–2.48)
HPV16/18 or TCT(ASCUS+) 85.17 (333/391) 94.94 (150/158) 89.93–97.63 21.46 (50/233) 16.48–27.40 45.05 (150/333) 39.64–50.57 86.21 (50/58) 74.07–93.44 2.22 1.11 (1.05–1.17) 0.65 (0.55–0.77) 1 1
HPV16/18 or ZNF671m 67.26 (263/391) 90.51 (143/158) 84.56–94.41 48.50 (113/233) 41.95–55.10 54.37 (143/263) 48.14–60.47 88.28 (113/128) 81.11–93.07 1.84 1.06 (0.98–1.15) 1.47 (1.17–1.83) 0.95 (0.90–1.01) 2.26 (1.78–2.87)
ZNF671m or TCT(ASCUS+) 82.10 (321/391) 93.04 (147/158) 87.58–96.30 25.32 (59/233) 19.97–31.50 45.79 (147/321) 40.27–51.42 84.29 (59/70) 73.20–91.52 2.18 1.09 (1.04–1.14) 0.77 (0.68–0.87) 0.98 (0.93–1.03) 1.18 (0.97–1.44)
HPV16/18 or ZNF671m or TCT(ASCUS+) 89.26 (349/391) 98.10 (155/158) 94.12–99.51 16.74 (39/233) 12.31–22.30 44.41 (155/349) 39.15–49.80 92.86 (39/42) 79.45–98.14 2.25 1.15 (1.08–1.23) 0.51 (0.41–0.63) 1.03 (1.00–1.06) 0.78 (0.67–0.90)

m, methylation; PPV, positive predictive values; NPV, positive predictive values; NNC, the number of colposcopies needed for detection per CIN3+ case.